Literature DB >> 8707092

Effects of longterm epidermal growth factor treatment on the normal rat colon.

P Kissmeyer-Nielsen1, L Vinter-Jensen, M Smerup.   

Abstract

BACKGROUND: Epidermal growth factor (EGF) exerts trophic effects on the mucosa of damaged and defunctioned colon, but the effects on the normal large bowel wall are not known. AIMS: To investigate the effect of systemic EGF treatment on growth and morphology of normal rat colon.
METHODS: Rats were treated with subcutaneous biosynthetic EGF injections of 150 micrograms/kg/day for 28 days. The weight of the histological colonic wall layers and the luminal surface area were measured using quantitative morphometric analysis (stereology). The colon was subdivided into proximal and distal parts.
RESULTS: EGF treatment increased the total colon wet weight by 23% compared with controls (p < 0.005). The weight increase occurred in the mucosal (33%) and the submucosal layers of the bowel wall (36%) and there was a 69% increase of the total luminal surface area (p = 0.001). In the proximal part of colon of EGF rats there was a 68% increase in mucosal weight (p < 0.005) accompanied by a 79% increase in the mucosal surface area compared with controls (p < 0.005), whereas submucosal and muscularis propria weights were identical. In distal colon, the mucosal weight increased 28% in the EGF group (p < 0.005), the mucosal surface area increased by 72% after treatment (p < 0.01). Furthermore there was a 34% increase in the weight of submucosa (p < 0.001) in the distal colon among EGF rats.
CONCLUSIONS: Treatment of rats with EGF has a stimulating role on the mucosa and luminal surface area of the entire functioning colon and a trophic effect on the submucosa of the distal colon.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8707092      PMCID: PMC1383119          DOI: 10.1136/gut.38.4.582

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  27 in total

1.  Insulin and epidermal growth factor. Human fibroblast receptors related to deoxyribonucleic acid synthesis and amino acid uptake.

Authors:  M D Hollenberg; P Cuatrecasas
Journal:  J Biol Chem       Date:  1975-05-25       Impact factor: 5.157

2.  Human epidermal growth factor and the proliferation of human fibroblasts.

Authors:  G Carpenter; S Cohen
Journal:  J Cell Physiol       Date:  1976-06       Impact factor: 6.384

3.  Estimation of surface area from vertical sections.

Authors:  A J Baddeley; H J Gundersen; L M Cruz-Orive
Journal:  J Microsc       Date:  1986-06       Impact factor: 1.758

4.  Urogastrone/epidermal growth factor in treatment of congenital microvillous atrophy.

Authors:  B Drumm; E Cutz; K B Tomkins; D Cook; J R Hamilton; P Sherman
Journal:  Lancet       Date:  1988-01-16       Impact factor: 79.321

5.  Intravenous epidermal growth factor/urogastrone increases small-intestinal cell proliferation in congenital microvillous atrophy.

Authors:  J A Walker-Smith; A D Phillips; N Walford; H Gregory; J D Fitzgerald; K MacCullagh; N A Wright
Journal:  Lancet       Date:  1985-11-30       Impact factor: 79.321

6.  Intravenous but not intragastric urogastrone-EGF is trophic to the intestine of parenterally fed rats.

Authors:  R A Goodlad; T J Wilson; W Lenton; H Gregory; K G McCullagh; N A Wright
Journal:  Gut       Date:  1987-05       Impact factor: 23.059

7.  Effect of epidermal growth factor (EGF) on blood flow and albumin extravasation in experimental granulation tissue.

Authors:  M Laato
Journal:  Acta Chir Scand       Date:  1986 Jun-Jul

8.  Effect of epidermal growth factor (EGF) on experimental granulation tissue.

Authors:  M Laato; J Niinikoski; C Lundberg; K E Arfors
Journal:  J Surg Res       Date:  1986-09       Impact factor: 2.192

9.  Stimulation of wound healing by epidermal growth factor. A dose-dependent effect.

Authors:  M Laato; J Niinikoski; L Lebel; B Gerdin
Journal:  Ann Surg       Date:  1986-04       Impact factor: 12.969

10.  Role of epidermal growth factor in healing of chronic gastroduodenal ulcers in rats.

Authors:  S J Konturek; A Dembinski; Z Warzecha; T Brzozowski; H Gregory
Journal:  Gastroenterology       Date:  1988-06       Impact factor: 22.682

View more
  4 in total

1.  Minimally invasive colorectal resection is associated with a rapid and sustained decrease in plasma levels of epidermal growth factor (EGF) in the colon cancer setting.

Authors:  Michael J Grieco; H M C Shantha Kumara; Raymond Baxter; Nadav Dujovny; Matthew F Kalady; Vesna Cekic; Martin Luchtefeld; Richard L Whelan
Journal:  Surg Endosc       Date:  2010-03-31       Impact factor: 4.584

2.  Morphological properties of zero-stress state in rat large intestine during systemic EGF treatment.

Authors:  Jian Yang; Jingbo Zhao; Yanjun Zeng; Lars Vinter-Jensen; Hans Gregersen
Journal:  Dig Dis Sci       Date:  2003-03       Impact factor: 3.199

3.  Effects of orally administered epidermal growth factor on enteropathogenic Escherichia coli infection in rabbits.

Authors:  A Buret; M E Olson; D G Gall; J A Hardin
Journal:  Infect Immun       Date:  1998-10       Impact factor: 3.441

Review 4.  Epidermal growth factor in clinical practice - a review of its biological actions, clinical indications and safety implications.

Authors:  Jorge Berlanga-Acosta; Jorge Gavilondo-Cowley; Pedro López-Saura; Tania González-López; María D Castro-Santana; Ernesto López-Mola; Gerardo Guillén-Nieto; Luis Herrera-Martinez
Journal:  Int Wound J       Date:  2009-10       Impact factor: 3.315

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.